Outcomes in biliary malignancy

Journal of Surgical Oncology

Volumn 110, Issue 5, 2014, Pages 585-591

  Groot Koerkamp, Bas ^a   Fong, Yuman ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

bile duct cancer; cholangiocarcinoma; gallbladder cancer; klatskin

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE; OXALIPLATIN;

ADJUVANT THERAPY; ARTIFICIAL EMBOLISM; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; GALLBLADDER CANCER; HUMAN; LIVER RESECTION; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIHILAR CHOLANGIOCARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SURGICAL MORTALITY; BILIARY TRACT NEOPLASMS; CHOLANGIOCARCINOMA; GALLBLADDER NEOPLASMS; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

BILIARY TRACT NEOPLASMS; CHOLANGIOCARCINOMA; GALLBLADDER NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84921764030     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23762     Document Type: Conference Paper

References (65)

1. Edge S, Byrd D, CC. C:, AJCC cancer staging handbook. 7th edition New York, NY: Springer; 2010.
2. Cancer Facts and Figures 2014: American Cancer Society; 2014. Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf.
3. DeOliveira ML, Cunningham SC, Cameron JL, et al.,: Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755-762.
4. Patel T:, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357.
5. Hezel AF, Zhu AX:, Systemic therapy for biliary tract cancers. Oncologist 2008; 13: 415-423.
6. Bridgewater J, Galle PR, Khan SA, et al.,: Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60: 1268-1289.
7. Patel AH, Harnois DM, Klee GG, et al.,: The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 204-207.
8. Corvera CU, Blumgart LH, Akhurst T, et al.,: 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 2008; 206: 57-65.
9. Valle JW, Furuse J, Jitlal M, et al.,: Cisplatin and gemcitabine for advanced biliary tract cancer: A meta-analysis of two randomised trials. Ann Oncol 2014; 25: 391-398.
10. Konstantinidis IT, Do RK, Gultekin DH, et al.,: Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: A potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol 2014; 21: 2675-2683.
11. de Jong MC, Nathan H, Sotiropoulos GC, et al.,: Intrahepatic cholangiocarcinoma: An international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29: 3140-3145.
12. Endo I, Gonen M, Yopp AC, et al.,: Intrahepatic cholangiocarcinoma: Rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008; 248: 84-96.
13. Shaib Y, El-Serag HB:, The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125.
14. Amini N, Ejaz A, Spolverato G, et al.,: Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: A population-based analysis. J Surg Oncol 2014; 110: 163-170.
15. Farges O, Fuks D, Boleslawski E, et al.,: Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: A multicenter study by the AFC-IHCC-2009 study group. Ann Surg 2011; 254: 824-829 discussion 30.
16. Jiang W, Zeng ZC, Tang ZY, et al.,: A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: The Fudan score. Ann Oncol 2011; 22: 1644-1652.
17. Ribero D, Pinna AD, Guglielmi A, et al.,: Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis of 434 patients. Arch Surg 2012; 147: 1107-1113.
18. Wang Y, Li J, Xia Y, et al.,: Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013; 31: 1188-1195.
19. Fu BS, Zhang T, Li H, et al.,: The role of liver transplantation for intrahepatic cholangiocarcinoma: A single-center experience. Eur Surg Res 2011; 47: 218-221.
20. Sotiropoulos GC, Kaiser GM, Lang H, et al.,: Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: A single-center experience. Transplant Proc 2008; 40: 3194-3195.
21. Sapisochin G, de Lope CR, Gastaca M, et al.,: Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A Spanish matched cohort multicenter study. Ann Surg 2014; 259: 944-952.
22. Mavros MN, Economopoulos KP, Alexiou VG, et al.,: Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. JAMA Surg 2014; [Epub ahead of print].
23. Hyder O, Hatzaras I, Sotiropoulos GC, et al.,: Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013; 153: 811-818.
24. Hyder O, Marques H, Pulitano C, et al.,: A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: An eastern and western experience. JAMA Surg 2014.
25. Frauenschuh D, Greim R, Kraas E:, How to proceed in patients with carcinoma detected after laparoscopic cholecystectomy. Langenbeck's Arch Surg/Deutsche Gesellschaft fur Chirurgie 2000; 385: 495-500.
26. Kwon AH, Imamura A, Kitade H, et al.,: Unsuspected gallbladder cancer diagnosed during or after laparoscopic cholecystectomy. J Surg Oncol 2008; 97: 241-245.
27. Hawkins WG, DeMatteo RP, Jarnagin WR, et al.,: Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 2004; 11: 310-315.
28. NCCN NCCN-. Hepatobiliary Cancers 2012 [cited 2013 02/27/2013]. Available from: http://www.nccn.org/professionals/physician-gls/pdf/hepatobiliary.pdf.
29. Lee SE, Jang JY, Lim CS, et al.,: Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol 2011; 17: 174-180.
30. Petrowsky H, Wildbrett P, Husarik DB, et al.,: Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006; 45: 43-50.
31. Maker AV, Butte JM, Oxenberg J, et al.,: Is port site resection necessary in the surgical management of gallbladder cancer ? Ann Surg Oncol 2012; 19: 409-417.
32. Araida T, Higuchi R, Hamano M, et al.,: Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: Results of a Japanese society of biliary surgery survey-a multicenter study. J Hepatobiliary Pancreat Surg 2009; 16: 204-215.
33. Pawlik TM, Gleisner AL, Vigano L, et al.,: Incidence of finding residual disease for incidental gallbladder carcinoma: Implications for re-resection. J Gastrointest Surg 2007; 11: 1478-1486 discussion 86-87.
34. Gumbs AA, Hoffman JP:, Laparoscopic completion radical cholecystectomy for T2 gallbladder cancer. Surg Endosc 2010; 24: 3221-3223.
35. Shen BY, Zhan Q, Deng XX, et al.,: Radical resection of gallbladder cancer: Could it be robotic ? Surg Endosc 2012; 26: 3245-3250.
36. Fong Y, Jarnagin W, Blumgart LH:, Gallbladder cancer: Comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000; 232: 557-569.
37. Mayo SC, Shore AD, Nathan H, et al.,: National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: A population-based analysis. J Gastrointest Surg 2010; 14: 1578-1591.
38. Do Carmo M, Perpetuo MO, Valdivieso M, et al.,: Natural history study of gallbladder cancer: A review of 36 years experience at M.D. Anderson Hospital and Tumor Institute. Cancer 1978; 42: 330-335.
39. Goetze TO, Paolucci V:, Immediate re-resection of T1 incidental gallbladder carcinomas: A survival analysis of the German Registry. Surg Endosc 2008; 22: 2462-2465.
40. Jarnagin WR, Ruo L, Little SA, et al.,: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 2003; 98: 1689-1700.
41. Wiggers JK, Groot Koerkamp B, Ovadia Z, et al.,: Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resection. HPB 2014; 16: 635-640.
42. Shindoh J, de Aretxabala X, Aloia TA, et al.,: Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: An international multicenter study. Ann Surg 2014; [Epub ahead of print].
43. Ito H, Ito K, D'Angelica M, et al.,: Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 2011; 254: 320-325.
44. Lee JM, Kim BW, Kim WH, et al.,: Clinical implication of bile spillage in patients undergoing laparoscopic cholecystectomy for gallbladder cancer. Am Surg 2011; 77: 697-701.
45. Kelly KJ, Dukleska K, Kuk D, et al.,: Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Ann Surg Oncol 2014; 21: 979-985.
46. Wang SJ, Lemieux A, Kalpathy-Cramer J, et al.,: Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol 2011; 29: 4627-4632.
47. Higuchi R, Yamamoto M:, Indications for portal vein embolization in perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21: 542-549.
48. Darwish Murad S, Kim WR, Harnois DM, et al.,: Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143: 88-98 e3; quiz e 14.
49. Nuzzo G, Giuliante F, Ardito F, et al.,: Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: Results of an Italian multicenter analysis of 440 patients. Arch Surg 2012; 147: 26-34.
50. Farges O, Regimbeau JM, Fuks D, et al.,: Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 2013; 100: 274-283.
51. Matsuo K, Rocha FG, Ito K, et al.,: The Blumgart preoperative staging system for hilar cholangiocarcinoma: Analysis of resectability and outcomes in 380 patients. J Am Coll Surg 2012; 215: 343-355.
52. Ebata T, Kosuge T, Hirano S, et al.,: Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg 2014; 101: 79-88.
53. Igami T, Nishio H, Ebata T, et al.,: Surgical treatment of hilar cholangiocarcinoma in the "new era": The Nagoya University experience. J Hepatobiliary Pancreat Sci 2010; 17: 449-454.
54. Kobayashi A, Miwa S, Nakata T, et al.,: Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg 2010; 97: 56-64.
55. Song SC, Choi DW, Kow AW, et al.,: Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ J Surg 2013; 83: 268-274.
56. Furusawa N, Kobayashi A, Yokoyama T, et al.,: Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg 2014; 38: 1164-1176.
57. Klempnauer J, Ridder GJ, von Wasielewski R, et al.,: Resectional surgery of hilar cholangiocarcinoma: A multivariate analysis of prognostic factors. J Clin Oncol 1997; 15: 947-954.
58. Lee SG, Song GW, Hwang S, et al.,: Surgical treatment of hilar cholangiocarcinoma in the new era: The Asan experience. J Hepatobiliary Pancreat Sci 2010; 17: 476-489.
59. Jarnagin WR, Fong Y, DeMatteo RP, et al.,: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-517; discussion 17-19.
60. Bismuth H, Corlette MB:, Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140: 170-178.
61. Deoliveira ML, Schulick RD, Nimura Y, et al.,: New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 2011; 53: 1363-1371.
62. Edge SB:, AJCC Cancer Staging Manual. 7th edition New York: Springer; 2010.
63. Horgan AM, Amir E, Walter T, et al.,: Adjuvant therapy in the treatment of biliary tract cancer: A systematic review and meta-analysis. J Clin Oncol 2012; 30: 1934-1940.
64. Wu ZF, Zhang HB, Yang N, et al.,: Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: Results of a large monocentric series. Eur J Surg Oncol 2012; 38: 602-610.
65. Groot Koerkamp B, Wiggers JK, Allen PJ, et al.,: AJCC staging for resected hilar cholangiocarcinoma: A comparison of the 6th and 7th edition. HPB In press. DOI: 10.1111/hpb.12320